Free Trial

Global X Genomics & Biotechnology ETF (GNOM) Short Interest Ratio & Short Volume

$8.07 -0.12 (-1.47%)
Closing price 03:59 PM Eastern
Extended Trading
$8.07 +0.00 (+0.06%)
As of 04:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Global X Genomics & Biotechnology ETF Short Interest Data

Global X Genomics & Biotechnology ETF (GNOM) has a short interest of 5,900 shares, representing 0.10% of the float (the number of shares available for trading by the public). This marks a -75.52% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 62,595 shares to cover all short positions.

Current Short Interest
5,900 shares
Previous Short Interest
24,100 shares
Change Vs. Previous Month
-75.52%
Dollar Volume Sold Short
$45,725.00
Short Interest Ratio
0.1 Days to Cover
Last Record Date
April 15, 2025
Outstanding Shares
6,060,000 shares
Short Percent of Float
0.10%
Today's Trading Volume
30,280 shares
Average Trading Volume
62,595 shares
Today's Volume Vs. Average
48%
Short Selling Global X Genomics & Biotechnology ETF?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

GNOM Short Interest Over Time

GNOM Days to Cover Over Time

GNOM Percentage of Float Shorted Over Time

Global X Genomics & Biotechnology ETF Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/20255,900 shares $45,725.00 -75.5%0.1%0.1 $7.75
3/31/202524,100 shares $191,595.00 +47.0%0.4%0.3 $7.95
3/15/202516,400 shares $144,976.00 +30.2%0.3%0.2 $8.84
2/28/202512,600 shares $116,298.00 -40.0%0.2%0.2 $9.23
2/15/202521,000 shares $208,110.00 +65.4%0.3%0.3 $9.91
1/31/202512,700 shares $129,286.00 -13.0%N/A0.2 $10.18
1/15/202514,600 shares $141,036.00 -45.3%N/A0.2 $9.66
12/31/202426,700 shares $259,257.00 -20.1%N/A0.4 $9.71
12/15/202433,400 shares $343,018.00 +62.1%N/A0.6 $10.27
11/30/202420,600 shares $223,304.00 +174.7%N/A0.5 $10.84
11/15/20247,500 shares $72,375.00 -44.0%N/A0.2 $9.65
10/31/202413,400 shares $139,092.00 -21.2%N/A0.3 $10.38
10/15/202417,000 shares $186,660.00 -7.1%N/A0.4 $10.98
9/30/202418,300 shares $205,875.00 +21.2%N/A0.3 $11.25
9/15/202415,100 shares $171,243.06 -41.5%N/A0.3 $11.34
8/31/202425,800 shares $293,604.00 +6.6%N/A0.5 $11.38
8/15/202424,200 shares $273,387.40 +70.4%N/A0.4 $11.30
7/31/202414,200 shares $165,146.00 -10.1%N/A0.3 $11.63
7/15/202415,800 shares $179,646.00 +47.7%N/A0.3 $11.37
6/30/202410,700 shares $111,708.00 -32.7%N/A0.2 $10.44
6/15/202415,900 shares $166,314.00 +62.2%N/A0.3 $10.46
5/31/20249,800 shares $99,470.00 -31.9%N/A0.2 $10.15
5/15/202414,400 shares $157,248.00 -22.6%N/A0.2 $10.92
4/30/202418,600 shares $183,210.00 +69.1%N/A0.2 $9.85
4/15/202411,000 shares $112,750.00 No ChangeN/A0.1 $10.25
3/31/202411,000 shares $125,180.00 -77.9%N/A0.2 $11.38
3/15/202449,800 shares $571,206.00 -12.0%N/A0.7 $11.47
2/29/202456,600 shares $678,068.00 +133.9%N/A0.7 $11.98
2/15/202424,200 shares $276,848.00 +15.8%N/A0.4 $11.44
1/31/202420,900 shares $224,675.00 -20.8%N/A0.3 $10.75
1/15/202426,400 shares $299,376.00 +80.8%N/A0.1 $11.34
12/31/202314,600 shares $168,748.26 -9.9%N/A0.1 $11.56
12/15/202316,200 shares $183,546.00 -61.6%N/A0.1 $11.33
11/30/202342,200 shares $439,724.00 +47.6%N/A0.1 $10.42
11/15/202328,600 shares $287,716.00 -41.3%N/A0.1 $10.06
10/31/202348,700 shares $430,995.00 -28.5%N/A0.2 $8.85
10/15/202368,100 shares $661,932.00 -14.8%N/A0.3 $9.72
9/30/202379,900 shares $812,583.00 +415.5%N/A0.4 $10.17
9/15/202315,500 shares $168,795.00 -95.9%N/A0.1 $10.89
8/31/2023374,700 shares $4.21 million +4,963.5%N/A3.5 $11.23
Musk's warning signal: Prepare before the cascade begins (Ad)

When Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t. With 40+ years of market modeling, he says Musk’s move wasn’t about efficiency — it was a signal. And what’s coming next could divide the market into winners and losers faster than anyone expects. Watch this urgent video briefing now.

Watch the Musk market warning before the dominoes fall
8/15/20237,400 shares $82,880.00 -54.9%N/A0.1 $11.20
7/31/202316,400 shares $201,228.00 -64.7%N/A0.2 $12.27
7/15/202346,400 shares $568,864.00 -32.0%N/A0.8 $12.26
6/30/202368,200 shares $826,584.00 +44.8%N/A0.9 $12.12
6/15/202347,100 shares $607,590.00 -32.2%N/A0.6 $12.90
5/31/202369,500 shares $849,290.00 +100.9%N/A0.8 $12.22
5/15/202334,600 shares $452,222.00 +16.1%N/A0.4 $13.07
4/30/202329,800 shares $365,348.00 -60.5%N/A0.3 $12.26
4/15/202375,400 shares $944,762.00 -26.7%N/A0.8 $12.53
3/31/2023102,800 shares $1.27 million +139.6%N/A1.1 $12.32
3/15/202342,900 shares $526,383.00 +29.2%N/A0.5 $12.27
2/28/202333,200 shares $419,316.00 -61.4%N/A0.3 $12.63
2/15/202386,100 shares $1.14 million -13.3%N/A0.9 $13.29
1/31/202399,300 shares $1.35 million -23.7%N/A1 $13.58
1/15/2023130,200 shares $1.77 million +45.0%N/A1.3 $13.60
12/30/202289,800 shares $1.14 million -15.1%N/A0.8 $12.65
12/15/2022105,800 shares $1.39 million +63.8%N/A1 $13.09
11/30/202264,600 shares $872,100.00 +36.6%N/A0.7 $13.50
11/15/202247,300 shares $648,956.00 +48.3%N/A0.5 $13.72
10/31/202231,900 shares $419,485.00 -55.8%N/A0.3 $13.15
10/15/202272,100 shares $876,015.00 No ChangeN/A0.7 $12.15
9/30/2022110,000 shares $1.38 million -60.7%N/A1 $12.55
9/15/2022279,900 shares $3.97 million +232.0%N/A2.2 $14.19
8/31/202284,300 shares $1.17 million -43.7%N/A0.6 $13.83
8/15/2022149,800 shares $2.44 million +22.0%N/A1.1 $16.28
7/31/2022122,800 shares $1.75 million -25.3%N/A0.6 $14.24
7/15/2022164,400 shares $2.32 million -23.2%N/A0.8 $14.09
6/30/2022214,100 shares $2.62 million +237.2%N/A1.1 $12.22
6/15/202263,500 shares $706,120.00 +56.0%N/A0.4 $11.12
5/31/202240,700 shares $488,400.00 +2.8%N/A0.3 $12.00
5/15/202239,600 shares $467,676.00 -44.2%N/A0.2 $11.81
4/30/202271,000 shares $904,540.00 +30.3%N/A0.7 $12.74
4/15/202254,500 shares $790,250.00 +16.2%N/A0.5 $14.50
3/31/202246,900 shares $704,907.00 -1.3%N/A0.4 $15.03
3/15/202247,500 shares $644,100.00 -57.7%N/A0.3 $13.56
2/28/2022112,300 shares $1.74 million +18.7%N/A0.8 $15.46
2/15/202294,600 shares $1.54 million -0.9%N/A0.7 $16.31
1/31/202295,500 shares $1.54 million +41.3%N/A0.7 $16.14
1/15/202267,600 shares $1.16 million -18.5%N/A0.5 $17.22
12/31/202182,900 shares $1.65 million +18.8%N/A0.7 $19.85
12/15/202169,800 shares $1.42 million -30.8%N/A0.7 $20.38
11/30/2021100,800 shares $2.08 million +72.9%N/A1.1 $20.62
11/15/202158,300 shares $1.23 million -20.6%N/A0.6 $21.02
10/29/202173,400 shares $1.57 million +1.4%N/A0.9 $21.43
10/15/202172,400 shares $1.55 million +11.9%N/A0.9 $21.46
9/30/202164,700 shares $1.43 million -55.8%N/A0.8 $22.14
9/15/2021146,200 shares $3.43 million +56.5%N/A1.6 $23.46
8/31/202193,400 shares $2.25 million -31.2%N/A1 $24.12
8/13/2021135,700 shares $3.12 million +18.8%N/A1.5 $22.98
7/30/2021114,200 shares $2.62 million +13.0%N/A1.3 $22.93
Musk's warning signal: Prepare before the cascade begins (Ad)

When Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t. With 40+ years of market modeling, he says Musk’s move wasn’t about efficiency — it was a signal. And what’s coming next could divide the market into winners and losers faster than anyone expects. Watch this urgent video briefing now.

Watch the Musk market warning before the dominoes fall
7/15/2021101,100 shares $2.29 million -14.7%N/A1.1 $22.64
6/30/2021118,500 shares $2.95 million -4.1%N/A1.2 $24.89
6/15/2021123,500 shares $2.82 million +17.6%N/A1.1 $22.83
5/28/2021105,000 shares $2.26 million -48.8%N/A1 $21.50
5/14/2021205,000 shares $4.05 million +42.7%N/A1.6 $19.75
4/30/2021143,700 shares $3.29 million -30.7%N/A0.9 $22.87
4/15/2021207,300 shares $4.67 million +33.1%N/A1.3 $22.55
3/31/2021155,800 shares $3.34 million -4.3%N/A0.9 $21.44
3/15/2021162,800 shares $3.82 million +59.9%N/A0.9 $23.45
2/26/2021101,800 shares $2.42 million -75.1%N/A0.6 $23.77
2/12/2021408,900 shares $11.23 million +228.2%N/A2.8 $27.47
1/29/2021124,600 shares $3.12 million -15.4%N/A1.1 $25.07
1/15/2021147,300 shares $3.88 million No ChangeN/A1.6 $26.32

GNOM Short Interest - Frequently Asked Questions

What is Global X Genomics & Biotechnology ETF's current short interest?

Short interest is the volume of Global X Genomics & Biotechnology ETF shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 5,900 shares of GNOM short. 0.10% of Global X Genomics & Biotechnology ETF's shares are currently sold short. Learn More on Global X Genomics & Biotechnology ETF's current short interest.

What is a good short interest percentage for Global X Genomics & Biotechnology ETF?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.10% of Global X Genomics & Biotechnology ETF's floating shares are currently sold short.

Is Global X Genomics & Biotechnology ETF's short interest increasing or decreasing?

Global X Genomics & Biotechnology ETF saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 5,900 shares, a decline of 75.5% from the previous total of 24,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Global X Genomics & Biotechnology ETF's short interest compare to its competitors?

0.10% of Global X Genomics & Biotechnology ETF's shares are currently sold short. Here is how the short interest of companies compare to Global X Genomics & Biotechnology ETF: Procure Space ETF (6.02%), Fidelity Disruptive Medicine ETF (0.00%), AOT Growth & Innovation ETF (0.36%), Spear Alpha ETF (4.03%), Tradr 2X Short Innovation Daily ETF (7.32%), Tema Cardiovascular and Metabolics ETF (0.04%), Siren Nasdaq NexGen Economy ETF (0.35%), Global X Aging Population ETF (0.03%), Democratic Large Cap Core ETF (1.61%), Sprott Energy Transition Materials ETF (0.75%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

What does it mean to sell short Global X Genomics & Biotechnology ETF stock?

Short selling GNOM is an investing strategy that aims to generate trading profit from Global X Genomics & Biotechnology ETF as its price is falling. GNOM shares are trading up $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Global X Genomics & Biotechnology ETF?

A short squeeze for Global X Genomics & Biotechnology ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GNOM, which in turn drives the price of the stock up even further.

How often is Global X Genomics & Biotechnology ETF's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNOM, twice per month. The most recent reporting period available is April, 15 2025.




This page (NASDAQ:GNOM) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners